ACZONE

Allergan, Inc.🇺🇸 United States

FDA Page

Effective Date: May 28, 2018
Approval ID: b7d605cf-bf84-461b-939b-1f773a4cba65
Products: 1 registered
Version: 15

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ACZONE Gel, 5% safely and effectively. See full prescribing information for ACZONE Gel, 5%. ACZONE (dapsone) Gel, 5%, for topical use Initial U.S. Approval: 1955

Quick Stats

Total Products1

Labelers2

Label Sections16

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.